Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan with Autologous Stem Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin Lymphoma
Title:
Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan with Autologous Stem Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin Lymphoma
Author:
Nieto, Yago Thall, Peter F. Ma, Junsheng Valdez, Benigno C. Ahmed, Sairah Anderlini, Paolo Popat, Uday Jones, Roy B. Shpall, Elizabeth J. Hosing, Chitra Qazilbash, Muzaffar Kebriaei, Partow Alousi, Amin Timmons, Melissa Gulbis, Alison Myers, Alan Oki, Yasuhiro Fanale, Michelle Dabaja, Bouthaina Pinnix, Chelsea Milgrom, Sarah Champlin, Richard Andersson, Borje S.
Appeared in:
Biology of blood and marrow transplantation
Paging:
Volume 24 () nr. 8 pages 1602-1609
Year:
2018
Contents:
Publisher:
The American Society for Blood and Marrow Transplantation